Prevalence of Heart Failure With Preserved Ejection Fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER Study (Identification of Patients With Heart Failure and PREserved Systolic Function: An Epidemiological Regional Study)

Dec 16, 2016 by in CARDIOLOGY Comments Off on Prevalence of Heart Failure With Preserved Ejection Fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER Study (Identification of Patients With Heart Failure and PREserved Systolic Function: An Epidemiological Regional Study)

The aims of the present study were to estimate the prevalence of heart failure (HF) with preserved ejection fraction (HF-PEF) in patients with HF and to compare their clinical characteristics…

read more

Association of Serum Uric Acid With Incident Atrial Fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study)

Dec 16, 2016 by in CARDIOLOGY Comments Off on Association of Serum Uric Acid With Incident Atrial Fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study)

Atrial fibrillation (AF) is one of the most common arrhythmias seen in clinical practice. Current evidence suggests that serum uric acid (SUA) could be a marker of oxidative damage, a…

read more

Impact of Sleep-Disordered Breathing, Visceral Fat Accumulation and Adiponectin Levels in Patients with Night-Time Onset of Acute Coronary Syndrome

Dec 16, 2016 by in CARDIOLOGY Comments Off on Impact of Sleep-Disordered Breathing, Visceral Fat Accumulation and Adiponectin Levels in Patients with Night-Time Onset of Acute Coronary Syndrome

Acute coronary syndrome (ACS) during sleep occurs at a relatively low frequency and the pathogenic background remains uncertain. The aim of the present study was to determine the significance of…

read more

An Assessment of the Concentration-Related Prognostic Value of Cardiac Troponin I Following Acute Coronary Syndrome

Dec 16, 2016 by in CARDIOLOGY Comments Off on An Assessment of the Concentration-Related Prognostic Value of Cardiac Troponin I Following Acute Coronary Syndrome

In 2004 the British Cardiac Society redefined myocardial infarction by cardiac troponin I (cTnI) concentration: ≤0.06 μg/L (unstable angina), >0.06 to <0.5 μg/L (myocardial necrosis), and ≥0.5 μg/L (myocardial infarction)….

read more

Comparison of Characteristics, Management Practices, and Outcomes of Patients Between the Global Registry and the Gulf Registry of Acute Coronary Events

Dec 16, 2016 by in CARDIOLOGY Comments Off on Comparison of Characteristics, Management Practices, and Outcomes of Patients Between the Global Registry and the Gulf Registry of Acute Coronary Events

The Arab Middle East is a unique region of the developing world where little is known about the outcomes of patients hospitalized with an acute coronary syndrome (ACS), despite playing…

read more

Comparison of Angioscopic Findings and Three-Year Cardiac Events Between Sirolimus -Eluting Stent and Bare-Metal Stent in Acute Myocardial Infarction

Dec 16, 2016 by in CARDIOLOGY Comments Off on Comparison of Angioscopic Findings and Three-Year Cardiac Events Between Sirolimus -Eluting Stent and Bare-Metal Stent in Acute Myocardial Infarction

The safety of sirolimus-eluting stents (SESs) in acute myocardial infarction (AMI) remains controversial. We compared long-term neointimal coverage after stent implantation for AMI evaluated by coronary angioscopy and 3-year clinical…

read more

Meta-Analysis of Randomized Controlled Trials of Intracoronary Versus Intravenous Administration of Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention for Acute Coronary Syndrome

Dec 16, 2016 by in CARDIOLOGY Comments Off on Meta-Analysis of Randomized Controlled Trials of Intracoronary Versus Intravenous Administration of Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention for Acute Coronary Syndrome

It is unclear whether intracoronary (IC) bolus administration of glycoprotein IIb/IIIa inhibitors (GPIs) during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes is superior to intravenous (IV) administration….

read more

Outcome of Sirolimus -Eluting Versus Zotarolimus -Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)

Dec 16, 2016 by in CARDIOLOGY Comments Off on Outcome of Sirolimus -Eluting Versus Zotarolimus -Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy)

Diabetes is associated with an increased risk of major adverse cardiac events after percutaneous coronary intervention. We compared clinical outcomes in patients with and without diabetes mellitus treated with the…

read more
Get Clinical Tree app for offline access